Skip to content

The impact of changing the form of the drug addiction

Comparison of two formoulation of drug addiction treatment (methadone tablets and syrup) in addiction treatment centers in Tehran 92 using a blind crossover design

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013050812666N1
Enrollment
100
Registered
2013-05-27
Start date
2013-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction. Mental and behavioural disorders due to psychoactive substance use (withdrawal state)

Interventions

Intervention 1: Patients are assigned to two groups of 60 and 40 people, 60 patients are currently being treated with the syrup while second group of 40 being treated with tablets at the baseline. Fir
Treatment - Drugs
Patients are assigned to two groups of 60 and 40 people, 60 patients are currently being treated with the syrup while second group of 40 being treated with tablets at the baseline. First group is divi
Intervention will be interchangeably performed in both groups, saying that every individual will be assigned in intervention and control groups.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: have been taken at least one month of maintenance therapy; have a positive drug dependency test; drug dose has not been changed during past one month; minimum dose of drug should not be less than 30 mg; during the one month of study do not intend to change his drug dose; responsible physician confirms the patient to continue the study. Exclusion criteria: liver failure; renal failure; acute psychological disease; less than 18 years of age; pregnancy; breastfeeding; severe physical illness.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Comparison of craving between two treatment groups. Timepoint: First - the end of the second week - the end of the study. Method of measurement: By questionnaire.;Comparison of morphine and amphetamine-positive test between groups. Timepoint: Beginning and end of the study. Method of measurement: Rapid test for morphine and amphetamines.

Secondary

MeasureTime frame
Comparison of the side effects of drug change in patients. Timepoint: At the end of the second week - the end of the study. Method of measurement: By questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheil Hassanipour

Tehran University of Medical Sciences

soheil.epid@gmail.com; s_hassanipour@razi.tums.ac.ir+98 18 2322 5176

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026